4.7 Article

Multicentre phase II study of cisplatin-etoposide chemotherapy for advanced large-cell neuroendocrine lung carcinoma: the GFPC 0302 study

Related references

Note: Only part of the references are listed.
Article Oncology

Advances in neuroendocrine lung tumors

W. D. Travis

ANNALS OF ONCOLOGY (2010)

Review Oncology

Large cell/neuroendocrine carcinoma

Russell Gollard et al.

LUNG CANCER (2010)

Article Cardiac & Cardiovascular Systems

Large-Cell Neuroendocrine Carcinoma of the Lung: An Aggressive Neuroendocrine Lung Cancer

Felix G. Fernandez et al.

SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY (2006)

Article Oncology

Neuroendocrine neoplasms of the lung: A prognostic spectrum

H Asamura et al.

JOURNAL OF CLINICAL ONCOLOGY (2006)

Article Cardiac & Cardiovascular Systems

Large cell neuroendocrine carcinoma: An aggressive form of non-small cell lung cancer

RJ Battafarano et al.

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2005)

Article Oncology

Complexity in the treatment of pulmonary large cell neuroendocrine carcinoma

T Kozuki et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2005)

Article Medicine, General & Internal

Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer

W Noda et al.

NEW ENGLAND JOURNAL OF MEDICINE (2002)